SMG vs. JAZZ
Compare and contrast key facts about The Scotts Miracle-Gro Company (SMG) and Jazz Pharmaceuticals plc (JAZZ).
Performance
SMG vs. JAZZ - Performance Comparison
Loading graphics...
SMG vs. JAZZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SMG The Scotts Miracle-Gro Company | 5.56% | -8.01% | 8.28% | 36.92% | -68.81% | -18.03% | 96.18% | 77.05% | -41.00% | 14.46% |
JAZZ Jazz Pharmaceuticals plc | 10.75% | 38.04% | 0.12% | -22.79% | 25.05% | -22.81% | 10.56% | 20.43% | -7.94% | 23.50% |
Fundamentals
SMG:
$3.53B
JAZZ:
$11.48B
SMG:
$1.55
JAZZ:
-$5.81
SMG:
1.06
JAZZ:
2.70
SMG:
$3.35B
JAZZ:
$4.27B
SMG:
$1.04B
JAZZ:
$5.11B
SMG:
$447.10M
JAZZ:
$835.63M
Returns By Period
In the year-to-date period, SMG achieves a 5.56% return, which is significantly lower than JAZZ's 10.75% return. Over the past 10 years, SMG has underperformed JAZZ with an annualized return of 1.42%, while JAZZ has yielded a comparatively higher 3.47% annualized return.
SMG
- 1D
- 0.33%
- 1M
- -13.31%
- YTD
- 5.56%
- 6M
- 6.84%
- 1Y
- 16.38%
- 3Y*
- -0.16%
- 5Y*
- -21.80%
- 10Y*
- 1.42%
JAZZ
- 1D
- -0.41%
- 1M
- -1.15%
- YTD
- 10.75%
- 6M
- 37.52%
- 1Y
- 50.63%
- 3Y*
- 8.76%
- 5Y*
- 2.65%
- 10Y*
- 3.47%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMG vs. JAZZ — Risk / Return Rank
SMG
JAZZ
SMG vs. JAZZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Scotts Miracle-Gro Company (SMG) and Jazz Pharmaceuticals plc (JAZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SMG | JAZZ | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.43 | 1.23 | -0.81 |
Sortino ratioReturn per unit of downside risk | 0.85 | 2.01 | -1.15 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.28 | -0.17 |
Calmar ratioReturn relative to maximum drawdown | 0.68 | 2.28 | -1.60 |
Martin ratioReturn relative to average drawdown | 1.31 | 5.53 | -4.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SMG | JAZZ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.43 | 1.23 | -0.81 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.48 | 0.08 | -0.56 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.04 | 0.11 | -0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.17 | +0.04 |
Correlation
The correlation between SMG and JAZZ is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SMG vs. JAZZ - Dividend Comparison
SMG's dividend yield for the trailing twelve months is around 4.33%, while JAZZ has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SMG The Scotts Miracle-Gro Company | 4.33% | 4.52% | 3.98% | 4.14% | 5.43% | 1.59% | 3.72% | 2.13% | 3.51% | 1.93% | 2.03% | 2.85% |
JAZZ Jazz Pharmaceuticals plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
SMG vs. JAZZ - Drawdown Comparison
The maximum SMG drawdown since its inception was -83.55%, smaller than the maximum JAZZ drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for SMG and JAZZ.
Loading graphics...
Drawdown Indicators
| SMG | JAZZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.55% | -96.90% | +13.35% |
Max Drawdown (1Y)Largest decline over 1 year | -23.85% | -22.67% | -1.18% |
Max Drawdown (5Y)Largest decline over 5 years | -83.55% | -47.55% | -36.00% |
Max Drawdown (10Y)Largest decline over 10 years | -83.55% | -52.10% | -31.45% |
Current DrawdownCurrent decline from peak | -71.06% | -4.35% | -66.71% |
Average DrawdownAverage peak-to-trough decline | -20.88% | -27.65% | +6.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.27% | 9.34% | +2.93% |
Volatility
SMG vs. JAZZ - Volatility Comparison
The Scotts Miracle-Gro Company (SMG) has a higher volatility of 14.01% compared to Jazz Pharmaceuticals plc (JAZZ) at 7.72%. This indicates that SMG's price experiences larger fluctuations and is considered to be riskier than JAZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SMG | JAZZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.01% | 7.72% | +6.29% |
Volatility (6M)Calculated over the trailing 6-month period | 22.89% | 29.45% | -6.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.62% | 41.23% | -2.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.95% | 31.51% | +14.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.05% | 32.72% | +7.33% |
Financials
SMG vs. JAZZ - Financials Comparison
This section allows you to compare key financial metrics between The Scotts Miracle-Gro Company and Jazz Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities